Laser Interstitial Thermotherapy (LITT) in Recurrent Glioblastoma: What Window of Opportunity for This Treatment?
Technology in Cancer Research & Treatment · 2024
DOI: 10.1177/15330338241249026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Alberto Morello und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Unit, Department of Neuroscience "Rita Levi Montalcini", "Città della Salute e della Scienza" University Hospital, University of Turin, …. Hauptthemen laut MEDLINE: Glioblastoma, Hyperthermia, Induced, Neoplasm Recurrence, Local, Laser Therapy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Laser Interstitial Thermotherapy is a minimally invasive treatment option in neurosurgery for intracranial tumors, including recurrent gliomas. The technique employs the thermal ablation of target tissue to achieve tumor control with real-time monitoring of the extent by magnetic resonance thermometry, allowing targeted thermal injury to the lesion. Laser Interstitial Thermotherapy has gained interest as a treatment option for recurrent gliomas due to its minimally invasive nature, shorter recovery times, ability to be used even in patients with numerous comorbidities, and potential to provide local tumor control. It can be used as a standalone treatment or combined with other therapies, such as chemotherapy or radiation therapy. We describe the most recent updates regarding several studies and case reports that have evaluated the efficacy and safety of Laser Interstitial Thermotherapy for recurrent gliomas. These studies have reported different outcomes, with some demonstrating promising results in terms of tumor control and patient survival, while others have shown mixed outcomes. The success of Laser Interstitial Thermotherapy depends on various factors, including tumor characteristics, patient selection, and the experience of the surgical team, but the future direction of treatment of recurrent gliomas will include a combined approach, comprising Laser Interstitial Thermotherapy, particularly in deep-seated brain regions. Well-designed prospective studies will be needed to establish with certainty the role of Laser Interstitial Thermotherapy in the treatment of recurrent glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurosurgery Unit, Department of Neuroscience "Rita Levi Montalcini", "Città della Salute e della Scienza" University Hospital, University of Turin, Turin, Italy.
- Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Faculty of Health Sciences, University of Pecs, Pecs, Hungary.
ORCID-Profile: Andrea Bianconi
Zitieren
APA
Morello, A., Bianconi, A., Rizzo, F., Bellomo, J., Meyer, A. C., Garbossa, D., Regli, L., & Cofano, F. (2024). Laser Interstitial Thermotherapy (LITT) in Recurrent Glioblastoma: What Window of Opportunity for This Treatment?. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241249026
Vancouver
Morello A, Bianconi A, Rizzo F, Bellomo J, Meyer AC, Garbossa D, et al. Laser Interstitial Thermotherapy (LITT) in Recurrent Glioblastoma: What Window of Opportunity for This Treatment?. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241249026
BibTeX
@article{Morello2024,
author = {Morello, Alberto and Bianconi, Andrea and Rizzo, Francesca and Bellomo, Jacopo and Meyer, Anna Cristina and Garbossa, Diego and Regli, Luca and Cofano, Fabio},
title = {Laser Interstitial Thermotherapy (LITT) in Recurrent Glioblastoma: What Window of Opportunity for This Treatment?},
journal = {Technology in Cancer Research & Treatment},
year = {2024},
doi = {10.1177/15330338241249026}
}
EUVIMED